- Home
- PTHL vs GXAI Comparison
PTHL vs GXAI Comparison
Compare PTHL & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- GXAI
- Stock Information
- Founded
- PTHL 1998
- GXAI 2021
- Country
- PTHL China
- GXAI United States
- Employees
- PTHL N/A
- GXAI N/A
- Industry
- PTHL
- GXAI
- Sector
- PTHL
- GXAI
- Exchange
- PTHL Nasdaq
- GXAI Nasdaq
- Market Cap
- PTHL 8.8M
- GXAI 9.3M
- IPO Year
- PTHL 2024
- GXAI 2023
- Fundamental
- Price
- PTHL $0.60
- GXAI $1.33
- Analyst Decision
- PTHL
- GXAI
- Analyst Count
- PTHL 0
- GXAI 0
- Target Price
- PTHL N/A
- GXAI N/A
- AVG Volume (30 Days)
- PTHL 119.0K
- GXAI 131.3K
- Earning Date
- PTHL 01-01-0001
- GXAI 11-13-2025
- Dividend Yield
- PTHL N/A
- GXAI N/A
- EPS Growth
- PTHL N/A
- GXAI N/A
- EPS
- PTHL N/A
- GXAI N/A
- Revenue
- PTHL $448,196.00
- GXAI $694,278.00
- Revenue This Year
- PTHL N/A
- GXAI N/A
- Revenue Next Year
- PTHL N/A
- GXAI N/A
- P/E Ratio
- PTHL N/A
- GXAI N/A
- Revenue Growth
- PTHL N/A
- GXAI 23205.74
- 52 Week Low
- PTHL $0.47
- GXAI $1.00
- 52 Week High
- PTHL $32.00
- GXAI $7.50
- Technical
- Relative Strength Index (RSI)
- PTHL 44.14
- GXAI 45.18
- Support Level
- PTHL $0.55
- GXAI $1.04
- Resistance Level
- PTHL $0.62
- GXAI $1.29
- Average True Range (ATR)
- PTHL 0.05
- GXAI 0.12
- MACD
- PTHL 0.02
- GXAI 0.01
- Stochastic Oscillator
- PTHL 58.80
- GXAI 54.29
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.